Management of delirium tremens on the head and neck service.
Alvi
A
A
Department of Otolaryngology, University of Pittsburgh School of Medicine, PA 15213, USA.
Gonzalez
R M
RM
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000430:Alcohol Withdrawal Delirium / Q000188:drug therapy*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use*; D004573:Electrolytes / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D004573:Electrolytes; D010640:Phenothiazines; D001569:Benzodiazepines; D001262:Atenolol; D008274:Magnesium; D013831:Thiamine